Assistant Professor, Medicine, Oregon Health and Science University
Oncology
Dr. Khaled A. Tolba, MD
|
|
Give Review
Khaled Tolba is an expert in the field of Oncology. He went to Cairo University School of Medicine. Khaled A. Tolba, MD is a published doctor and has 12 publications published. The lastest was: 'A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid tumors.' Dr. Khaled A. Tolba accepts Medicare.
Publications
- A phase I dose-escalation trial of 2-deoxy-D-glucose alone or combined with docetaxel in patients with advanced solid Tumors.
- Adoptively transferred tumor-specific T Cells stimulated ex vivo using herpes simplex virus amplicons encoding 4-1BBL persist in the host and show antitumor activity i...
- Herpes simplex virus (HSV) amplicon-mediated codeLivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
- HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic Leukemia.
- Augmentation of anti-tumor responses of adoptively transferred CD8+T Cells in the lymphopenic setting by HSV amplicon transduction.
- HSV ICP0 recruits USP7 to modulate TLR-mediated innate response.
- Efficacy and toxicity of chemoradiotherapy with carboplatin and irinotecan followed by consolidation docetaxel for unresectable stage III non-small cell lung Cancer.
- DeLivery of NKG2D ligand using an anti-HER2 antibody-NKG2D ligand fusion protein results in an enhanced innate and adaptive antitumor response.
- Potential role of chemokines in immune therapy of Cancer.
- Modulation of dendritic Cell differentiation and function by YopJ of Yersinia pestis.
- Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic Leukemia.
Schools
Bani Swief Branch University Of Cairo University Of Cairo Faculty Of Medicine
Newton Wellesley Hospital
Strong Mem Hsp University Rochester
Procedures Preformed
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Oncology
Accepted Insurances
Education
-
University of Rochester -
Cairo University School of Medicine
Drug Facts
| NPI NUMBER | 1093828311 | |
| NPPES Provider LastName | TOLBA | |
| NPPES Provider FirstName | KHALED | |
| NPPES Provider ZIPCode | 331361005 | |
| NPPES Provider State | FL | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 441.0 | |
| Distinct Opioid Count | 5.0 | |
| Opioid Claim Count | 100.0 | |
| Percent Opioid Claims | 22.68 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093828311 |
| Last Name Of The Provider | TOLBA |
| First Name Of The Provider | KHALED |
| View All |
Similar Doctors
|
|
Dr. Pasquale W. Benedetto, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles L. Vogel, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Lisa D. Reale, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lionel Noy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald S. Ernst, MD
This Doctor is OpenDoctor Recommended.
|